PharmD Info

A forum for Indian Pharmacy Professionals

Important: Registered today to have the complete access on this forum --- Register Here
Discuss various Doctor of Pharmacy Knowledge based topics
  • User avatar
#660
According to results presented at the Heart Failure Society of America Annual Scientific Meeting, dose reduction occurred in 42% of the valsartan/sacubitril group and 43% of the enalapril group during the course of the study. Hypotension was the most cited reason for dose reduction in the valsartan/sacubitril group and cough in the enalapril group. Dose reduction was more common in patients who were older, sicker, had higher levels of serum creatinine and NT-proBNP at baseline, and had an implantable cardioverter defibrillator or cardiac resynchronization therapy device, according to Orly Vardeny, PharmD, MS, from the University of Wisconsin School of Pharmacy.

http://www.healio.com/cardiology/hf-tra ... ower-doses
Similar Topics
Topics Statistics Last post
0 Replies 
401 Views
by rahmatulla.syed
17 Jan 2018, 18:59
0 Replies 
1270 Views
by Admin
23 Mar 2017, 17:00
List of Drug of Choice
by unbreakable  - 16 Jun 2018, 12:54  - In: Pharm D Topics
0 Replies 
707 Views
by unbreakable
16 Jun 2018, 12:54
FDA - Drug Safety Podcasts
by unbreakable  - 16 May 2018, 14:40  - In: Drug Safety Alerts
0 Replies 
407 Views
by unbreakable
16 May 2018, 14:40
Prescription Drug Abuse
by unbreakable  - 02 Feb 2018, 16:11  - In: Drug & Poison Information
0 Replies 
567 Views
by unbreakable
02 Feb 2018, 16:11

Tags

Hello Everyone

This is the best thing i do today to be a member i[…]

https://i.imgur.com/WzzIkLJ.jpg

https://i.imgur.com/xUyNEY4.jpg

Dear Sir/Madam, This is for your kind information[…]

WELCOME TO OUR E-LEARN COURSE WORK MODULES